PacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research
June 14, 2023
Collaboration Aims to Show Utility and Cost Effectiveness of HiFi Sequencing in Clinical Research Settings, Using Revio Systems MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions today announced a clinical research study with Radboud University Medical Center (Radboudumc) to explore genetic causes of rare and genetic diseases. Together with Radboud's Department [...]
Bruker Releases 2023 Sustainability Report
June 14, 2023
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today released its 2023 Sustainability Report, highlighting how Bruker’s spirit of ‘Innovation with Integrity’ is advancing science and technology, medicine and health, as well as safety and prosperity in a responsible, sustainable manner. The report also provides an overview of Bruker’s ESG strategy, initiatives and performance. “We are pleased [...]
Nanotein Launches Revolutionary NK Cell Soluble Activator for Cancer Immunotherapy Research
June 14, 2023
Nanotein Technologies adds to its best-in-class NanoSpark™ reagent line, with the launch of NanoSpark™ GROW-NK, a high-performance reagent for the ex vivo activation and expansion of Natural Killer cells, in an easy-to-use, feeder cell free format. BERKELEY, Calif. -- Nanotein Technologies, a trailblazing leader in innovative cell therapy reagents, recently launched their latest addition to the NanoSpark™ product [...]
June 14, 2023
TOKYO -- PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd. (headquarters: Singapore, hereafter SciMed), making SciMed a wholly owned subsidiary of PHCHD. PHCHD previously owned a 70% stake in SciMed. PHC Group, a global [...]
Complete Genomics Announces Updated Mission and New Partnerships on 18th Anniversary
June 14, 2023
SAN JOSE, Calif. -- Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary. Aligned with this new mission, Complete Genomics announced multiple donations for advancing genomics education and cancer care, as well as key [...]
June 14, 2023
Wetzlar, Germany – Leica Microsystems, a leader in microscopy and scientific instrumentation, today announced that its President, Dr Annette Rinck, has been appointed to the University Council of the Philipps University of Marburg. Dr Rinck was appointed following a recommendation made by the Hessian Ministry of Science. The Senate of Philipps University has now confirmed her [...]
L7 Informatics Supports Cancer Research at Dana Farber Cancer Institute with L7|ESP™
June 13, 2023
L7|ESP™ streamlines operations and facilitates a seamless flow of information. AUSTIN, Texas — L7 Informatics, provider of the leading unified platform for integrated data and workflow solutions for the life sciences industry, announces the implementation of their flagship product, L7|ESP software, at the Connell and O’Reilly Families Cell Manipulation Core Facility (CMCF) of the prestigious Dana-Farber [...]
Applied StemCell Inc. partners with CIRM | ASC
June 13, 2023
Applied StemCell Inc. partners with CIRM to provide clinical-grade iPSCs and access to its proprietary gene editing technologies to accelerate the development of regenerative therapies Milpitas, CA USA: Applied StemCell, Inc. (ASC) and the California Institute for Regenerative Medicine (CIRM) have partnered as Industry Resource Partners. ASC is offering its IP-based gene insertion technology and TARGATT [...]
Promega Commits to 100% Renewable Electricity by 2025
June 13, 2023
Biotechnology company announces pledge in annual Corporate Responsibility Report Madison, WI USA. -- Promega Corporation has committed to sourcing 100% of its global electricity usage from renewable sources by 2025. The Wisconsin-based biotechnology manufacturer will continue scaling up renewable electricity production at its facilities, partnering on local projects and purchasing renewable credits where necessary. This move [...]
Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids
June 13, 2023
New plasmids will help accelerate and standardize lentiviral vector development from clinical to commercial manufacturing WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies. Cell and [...]

